Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
francesco.panzuto@uniroma1.it
Francesco Panzuto
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
francesco.panzuto@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
GASTROENTEROLOGY
2018
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
ENDOCRINE-RELATED CANCER
2018
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms
THE ONCOLOGIST
2018
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study
HPB
2018
Therapy for Locoregional Disease. Stomach/Duodenum, Colon/Rectum
Neuroendocrine Tumors in Real Life
2018
Evaluation of the relationships between computed tomography features, pathological findings, and rrognostic risk assessment in gastrointestinal stromal tumors
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
2017
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
PLOS ONE
2017
Functional imaging in the follow-up of enteropancreatic neuroendocrine tumors: Clinical usefulness and indications
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2017
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2017
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors
CANCER MEDICINE
2017
Lack of association for reported endocrine pancreatic cancer risk Loci in the PANDoRA consortium
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
2017
Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome
THE ONCOLOGIST
2017
Everolimus in pancreatic neuroendocrine carcinomas G3
PANCREAS
2017
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors. a systematic review and meta-analysis
ONCOTARGET
2017
A case of pancreatic small cell neuroendocrine carcinoma associated with SIADH
PANCREAS
2016
Digestive neuroendocrine neoplasms. A 2016 overview
DIGESTIVE AND LIVER DISEASE
2016
Controversies in the treatment of digestive neuroendocrine tumors
JOURNAL OF CANCER METASTASIS AND TREATMENT
2016
Risk and protective factors for small intestine neuroendocrine tumors: a prospective case-control study
NEUROENDOCRINOLOGY
2016
« prima
< precedente
1
2
3
4
5
6
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma